JP2008523140A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523140A5
JP2008523140A5 JP2007546603A JP2007546603A JP2008523140A5 JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5 JP 2007546603 A JP2007546603 A JP 2007546603A JP 2007546603 A JP2007546603 A JP 2007546603A JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5
Authority
JP
Japan
Prior art keywords
separation matrix
matrix according
particles
binding protein
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007546603A
Other languages
English (en)
Japanese (ja)
Other versions
JP5787461B2 (ja
JP2008523140A (ja
Filing date
Publication date
Priority claimed from SE0403057A external-priority patent/SE0403057D0/sv
Application filed filed Critical
Priority claimed from PCT/SE2005/001900 external-priority patent/WO2006065208A1/en
Publication of JP2008523140A publication Critical patent/JP2008523140A/ja
Publication of JP2008523140A5 publication Critical patent/JP2008523140A5/ja
Application granted granted Critical
Publication of JP5787461B2 publication Critical patent/JP5787461B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007546603A 2004-12-14 2005-12-12 免疫グロブリンの精製方法 Expired - Lifetime JP5787461B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0403057A SE0403057D0 (sv) 2004-12-14 2004-12-14 Purification of immunoglobulins
SE0403057-3 2004-12-14
US63831604P 2004-12-22 2004-12-22
US60/638,316 2004-12-22
PCT/SE2005/001900 WO2006065208A1 (en) 2004-12-14 2005-12-12 Purification of immunoglobulins

Publications (3)

Publication Number Publication Date
JP2008523140A JP2008523140A (ja) 2008-07-03
JP2008523140A5 true JP2008523140A5 (https=) 2008-12-11
JP5787461B2 JP5787461B2 (ja) 2015-09-30

Family

ID=36588164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007546603A Expired - Lifetime JP5787461B2 (ja) 2004-12-14 2005-12-12 免疫グロブリンの精製方法

Country Status (5)

Country Link
EP (1) EP1830947A4 (https=)
JP (1) JP5787461B2 (https=)
AU (1) AU2005317279C1 (https=)
CA (1) CA2586803C (https=)
WO (1) WO2006065208A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3050963B1 (en) 2005-03-31 2019-09-18 Chugai Seiyaku Kabushiki Kaisha Process for production of polypeptide by regulation of assembly
ES2892925T3 (es) 2006-03-31 2022-02-07 Chugai Pharmaceutical Co Ltd Métodos para controlar la farmacocinética en sangre de anticuerpos
US9670269B2 (en) 2006-03-31 2017-06-06 Chugai Seiyaku Kabushiki Kaisha Methods of modifying antibodies for purification of bispecific antibodies
EP2066419B1 (en) 2006-09-29 2015-11-11 GE Healthcare Bio-Sciences AB Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
CN101874042B9 (zh) 2007-09-26 2019-01-01 中外制药株式会社 利用cdr的氨基酸取代来改变抗体等电点的方法
AU2008304748C1 (en) 2007-09-26 2014-06-12 Chugai Seiyaku Kabushiki Kaisha Modified antibody constant region
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
JP5889181B2 (ja) 2010-03-04 2016-03-22 中外製薬株式会社 抗体定常領域改変体
JP5917417B2 (ja) * 2010-03-05 2016-05-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗体の選択的強化
US8859294B2 (en) 2010-03-17 2014-10-14 Panasonic Corporation Method for binding a protein consisting of protein A or consisting of at least one domain of the A to E domains of the protein A to the substrate
WO2011114405A1 (en) * 2010-03-17 2011-09-22 Panasonic Corporation A method for binding a protein consisting of protein a or consisting of at least one domain of the a to e domains of the protein a to the substrate
JP5998050B2 (ja) 2010-03-31 2016-09-28 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
WO2011125673A1 (ja) 2010-03-31 2011-10-13 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
PH12016502073B1 (en) 2010-11-17 2024-04-05 Chugai Pharmaceutical Co Ltd Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
RS67768B1 (sr) 2010-11-30 2026-03-31 Chugai Pharmaceutical Co Ltd Terapijski agens koji indukuje citotoksičnost
WO2015030094A1 (ja) 2013-08-30 2015-03-05 株式会社カネカ Ｆａｂ領域結合性ペプチド
EP3042192A4 (en) * 2013-09-04 2017-04-26 Sten Ohlson Weak affinity chromatography
JP6230853B2 (ja) * 2013-09-06 2017-11-15 株式会社日立製作所 タンパク質の精製方法及び精製装置
JP6534615B2 (ja) 2013-09-27 2019-06-26 中外製薬株式会社 ポリペプチド異種多量体の製造方法
US20170043320A1 (en) 2013-11-27 2017-02-16 Jsr Corporation Solid-phase carrier, production method for solid-phase carrier, carrier for affinity refining, production method for filler for affinity chromatography, filler for affinity chromatography, chromatography column, and refining method
US10610807B2 (en) 2014-01-17 2020-04-07 Repligen Corporation Sterilizing chromatography columns
CN106795215A (zh) 2014-06-24 2017-05-31 通用电气医疗集团生物工艺研发股份公司 层析方法
EP3162809B1 (en) 2014-06-27 2021-08-04 JSR Corporation Carrier for affinity chromatography
WO2016031902A1 (ja) * 2014-08-28 2016-03-03 株式会社カネカ Ｆａｂ領域含有ペプチド用アフィニティー分離マトリックス
WO2016121701A1 (ja) 2015-01-26 2016-08-04 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
JP6663360B2 (ja) 2015-01-26 2020-03-11 株式会社カネカ 変異型免疫グロブリンκ鎖可変領域結合性ペプチド
JP7082484B2 (ja) 2015-04-01 2022-06-08 中外製薬株式会社 ポリペプチド異種多量体の製造方法
CN108368166B (zh) * 2015-12-28 2023-03-28 中外制药株式会社 提高含fc区多肽纯化效率的方法
MA44780A (fr) 2016-04-28 2019-03-06 Chugai Pharmaceutical Co Ltd Préparation contenant un anticorps
WO2017195638A1 (ja) 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
WO2017195641A1 (ja) * 2016-05-11 2017-11-16 株式会社カネカ アフィニティ分離マトリックスの製造方法およびアフィニティ分離マトリックス
GB201703116D0 (en) * 2017-02-27 2017-04-12 Ge Healthcare Bioprocess R&D Ab A seperation matrix and a method of seperating antibodies
CN110461358A (zh) 2017-03-31 2019-11-15 公立大学法人奈良县立医科大学 可用于预防和/或治疗凝血因子ⅸ异常、包含代替凝血因子ⅷ的功能的多特异性抗原结合分子的药物组合物
AU2018361430B2 (en) 2017-11-01 2025-08-14 Chugai Seiyaku Kabushiki Kaisha Antibody variant and isoform with lowered biological activity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5089605A (en) * 1987-03-13 1992-02-18 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5445732A (en) * 1992-06-19 1995-08-29 Sepracor Inc. Passivated porous polymer supports and methods for the preparation and use of same
EP0693085B1 (en) * 1993-03-29 2001-10-31 Minnesota Mining And Manufacturing Company Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
SE9503925D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
SE9601368D0 (sv) * 1996-04-11 1996-04-11 Pharmacia Biotech Ab Process for the production of a porous cross-linked polysaccharide gel
EP0955332B1 (en) * 1997-01-07 2006-07-19 Kaneka Corporation Adsorbent for body fluid purification
SE9700383D0 (sv) * 1997-02-04 1997-02-04 Pharmacia Biotech Ab An adsorption/separation method and a medium for adsorption/separation
SE0004929D0 (sv) * 2000-12-29 2000-12-29 Apbiotech Ab A method for producing liquid chromatography matrices
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
SE0300482D0 (sv) * 2003-02-21 2003-02-21 Amersham Biosciences Ab Inorganic beads with hierarchical pore structures
US7700743B2 (en) * 2003-07-22 2010-04-20 Millipore Corporation Immobilised affinity medium and its use in separation
US20080312425A1 (en) * 2004-08-30 2008-12-18 Lonza Biologics Plc. Ion Exchange Chromatography and Purification of Antibodies

Similar Documents

Publication Publication Date Title
JP2008523140A5 (https=)
Madathiparambil Visalakshan et al. The influence of nanoparticle shape on protein corona formation
Kumar et al. Affinity fractionation of lymphocytes using a monolithic cryogel
Saylan et al. Supermacroporous composite cryogels in biomedical applications
Purtov et al. Nanodiamonds as carriers for address delivery of biologically active substances
WO2006066598A3 (en) Antibody binding affinity ligands
Gooding et al. Hplc of biological macro-molecules, revised and expanded
Titirici et al. Hierarchical imprinting using crude solid phase peptide synthesis products as templates
Salimi et al. Protein A and protein A/G coupled magnetic SiO2 microspheres for affinity purification of immunoglobulin G
Vallhov et al. Dendritic cell‐derived exosomes carry the major cat allergen F el d 1 and induce an allergic immune response
BRPI0606375A2 (pt) método de produzir um sistema catalisador heterogêneo, sistema catalisador, e, método de catálise
Caurie Hysteresis phenomenon in foods
Chen et al. High performance of a unique mesoporous polystyrene-based adsorbent for blood purification
Weber et al. Development of specific adsorbents for human tumor necrosis factor-α: Influence of antibody immobilization on performance and biocompatibility
Mhemeed A general overview on the adsorption
JP2010534336A5 (https=)
JPS60501209A (ja) 生物学的活性物質の精製方法
Xu et al. Feasibility of using DNA-immobilized nanocellulose-based immunoadsorbent for systemic lupus erythematosus plasmapheresis
Akkaya et al. Concanavalin A immobilized magnetic poly (glycidyl methacrylate) beads for antibody purification
Ettenauer et al. Characterization and functionalization of cellulose microbeads for extracorporeal blood purification
Soares et al. Molecular imprinting of β-cyclodextrin/cholesterol template into a silica polymer for cholesterol separation
Weber et al. Development of affinity microparticles for extracorporeal blood purification based on crystalline bacterial cell surface proteins
SE0403057D0 (sv) Purification of immunoglobulins
Thipe et al. Hybrid nanomaterials for detection, detoxification, and management mycotoxins
Öztürk et al. Preparation of poly (2‐hydroxyethyl methacrylate)‐grafted chitosan‐montmorillonite superabsorbent nanocomposite for adsorption of bovine serum albumin